GRHL2 and deafness: In the future, this approach may be used to test the feasibility of treating other inherited deafness cases in which the SV is the predominant site affected (e.g. mutations in KCNE1, CCDC50, DFNA5, MYH14, TFCP2L3, TMPRSS3 genes).